Tender detail

Non-exclusive rebate agreement for glycopyrronium + indacaterol under Section 130a(8) SGB V, 1 January 2027 to 31 December 2028

Summary

DAK-Gesundheit intends to conclude non-exclusive medicine rebate agreements with interested pharmaceutical companies for medicines containing the active ingredients glycopyrronium and indacaterol (ATC R03AL12). The agreement is intended to run from 1 January 2027 to 31 December 2028, but will end automatically if an exclusive agreement takes effect earlier.

Reference number
4f90c16c-6a50-49c1-99cd-dff8b336d9eb
Buyer
Country
Germany (DEU)
Procedure
Open procedure
CPV
33600000 Pharmaceutical products
Deadline
2028-11-05
Status
Open
Contract subject
Supplies
Estimated value
1,00 EUR
Source
DEU_BKMS

More tender information after sign-in

The public view shows key tender details. Sign in to open official links, documents and AI tender support.